{
  "nct_id": "NCT61924903",
  "indication": "Multiple Sclerosis",
  "phase": "Phase 2",
  "sample_size": 240,
  "duration_weeks": 64,
  "dropout_rate": 0.46,
  "primary_endpoints": [
    "MRI lesion count"
  ],
  "secondary_endpoints": [
    "EDSS progression",
    "MRI lesion count"
  ],
  "blinding": "open-label",
  "control_arm": "standard of care",
  "outcome_summary": "Study no significant difference compared to placebo.",
  "success": false,
  "failure_reason": "Insufficient efficacy"
}